News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

National Institutes of Health (NIH) Begins Study of CHF Solutions, Inc.' Aquapheresis(TM) Therapy



9/2/2008 11:10:48 AM

BROOKLYN PARK, Minn.--(BUSINESS WIRE)--The National Institutes of Health (NIH) has informed CHF Solutions, Inc. that the CARRESS-HF trial has begun enrolling patients. Sponsored by NIH’s National Heart, Lung, and Blood Institute and chosen out of 16 national submissions for studies in heart failure, this study will compare CHF Solutions’ unique Aquapheresis therapy with standard medical drug therapy in patients hospitalized with acute decompensated heart failure (ADHF) and cardiorenal syndrome.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES